N,N’-Dinitrosopiperazine(Synonyms: 1,4-Dinitrosopiperazine; DNP)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

N,N’-Dinitrosopiperazine (Synonyms: 1,4-Dinitrosopiperazine; DNP)

N,N’-Dinitrosopiperazine (1,4-Dinitrosopiperazine; DNP) 是一种致癌物 (carcinogen)，特异性针对鼻咽癌，可促进鼻咽癌的转移。N,N’-Dinitrosopiperazine 通过蛋白磷酸化调节多种信号通路，包括 LYRIC，在丝氨酸 568 位。

N,N

N,N’-Dinitrosopiperazine Chemical Structure

CAS No. : 140-79-4

规格 价格 是否有货
25 mg ￥600 询问价格 & 货期
50 mg ￥900 询问价格 & 货期
100 mg ￥1500 询问价格 & 货期

* Please select Quantity before adding items.

生物活性

N,N’-Dinitrosopiperazine (1,4-Dinitrosopiperazine; DNP) is a carcinogen with specificity for nasopharyngeal epithelium and facilitates NPC metastasis. N,N’-Dinitrosopiperazine regulates multiple signaling pathways through protein phosphorylation, including LYRIC at serine 568[1].

体外研究
(In Vitro)

N,N’-Dinitrosopiperazine (0.5-100 μM; 48 hours) has no inhibitory effects on the labeled 6-10B cells, and LDH activity is not significantly altered by DNP treatment in the 0.5-8 μM concentration range. However, it is cytotoxic from the concentration 10 μM[1].
N,N’-Dinitrosopiperazine (2-8 μM; 24 hours) induces 6-10B cell invasion and motility in a dose-dependent manner. At 6 μM, when compares to the control group, DNP increases cell invasion at 421.7% and cell motility is increased by 328.2%[1].
N,N’-Dinitrosopiperazine (6 μM; 24 hours) increases the expression of phospho-LYRIC s568 and LYRIC expression in CNE1 cells[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: The labeled 6-10B cells
Concentration: 0.5, 1, 2, 4, 6, 8, 10, 20, 40, 80, or 100 μM
Incubation Time: 48 hours
Result: Had no inhibitory effects at the concentration 0-8 μM.

Western Blot Analysis[1]

Cell Line: The NPC cell line CNE1
Concentration: 6 μM
Incubation Time: 24 hours
Result: Increased phospho-LYRIC s568 and LYRIC expression.

体内研究
(In Vivo)

N,N’-Dinitrosopiperazine (injected into the tail veins; 40 mg/kg; 30 days) inhibits cell motility and invasion, and facilitates NPC metastasis in vivo. From a IHC result, Phospho-LYRIC expression is higher in the metastatic tumors of DNP-treated mice than in those of the untreated control mice[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BABL/c nude mice injected with labeled 6-10B cell suspensions (1 × 104 cells) with or without DNP(40 mg/kg)[1]
Dosage: 40 mg/kg
Administration: Injected into the tail veins; 30 days
Result: Induced LYRIC phosphorylation at serine 568 associated with NPC metastasis in vivo.

分子量

144.13

Formula

C4H8N4O2
CAS 号

140-79-4
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Damao Huang, et al. Identification of Novel Signaling Components in N,N’-dinitrosopiperazine-mediated Metastasis of Nasopharyngeal Carcinoma by Quantitative Phosphoproteomics. BMC Cancer. 2014 Apr 5;14:243.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务